Pasithea Therapeutics Corp. (KTTA) shareholders
Close on Nov 18, 2026Market cap $17.07MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Vivo Opportunity Fund Holdings, L.P. Joint filing with Vivo Opportunity, LLC (9.99%), Vivo Opportunity Cayman Fund, L.P. (9.99%) and 1 more | 17,560,467 | 9.99% | 13G (passive) | Dec 1, 2025 |
| Janus Henderson Group PLC | 10,229,652 | 9.99% | 13G (passive) | Nov 28, 2025 |
| Vivo Opportunity, LLC Joint filing with Vivo Opportunity Fund Holdings, L.P. (9.99%), Vivo Opportunity Cayman Fund, L.P. (9.99%) and 1 more | 9,286,738 | 9.99% | 13G (passive) amendment | Jun 30, 2026 |
| Coastlands Capital GP LLC Joint filing with Coastlands Capital LP (11.48%), Coastlands Capital Partners LP (11.48%) and 2 more | 3,835,035 | 11.48% | 13G (passive) amendment | Apr 9, 2026 |
| Opaleye Management Inc. Joint filing with Opaleye, L.P. (9.99%), James Silverman (9.99%) | 2,491,000 | 9.99% | 13G (passive) | Apr 1, 2026 |
| Coastlands Capital LLC Joint filing with Coastlands Capital LP (9.99%), Coastlands Capital Partners LP (9.99%) and 2 more | 2,394,765 | 9.99% | 13G (passive) | Feb 23, 2026 |
| Adage Capital Management, L.P. Joint filing with Robert Atchinson (9.99%), Phillip Gross (9.99%) | 2,329,749 | 9.99% | 13G (passive) | Dec 31, 2025 |
| Squadron Capital Management LLC Joint filing with Squadron Master Fund LP (9.90%), Matthew Sesterhenn (9.90%) and 1 more | 2,329,749 | 9.90% | 13G (passive) amendment | Dec 31, 2025 |
| Matthew Sesterhenn Joint filing with Squadron Capital Management LLC (9.90%), William Blank (9.90%) and 1 more | 2,252,930 | 9.90% | 13G (passive) | Nov 28, 2025 |
| Opaleye, L.P. Joint filing with Opaleye Management Inc. (6.14%), James Silverman (6.14%) | 2,050,000 | 6.14% | 13G (passive) amendment | Jun 30, 2026 |
| Stonepine Capital Management, LLC Joint filing with Stonepine Capital, L.P. (5.80%), Stonepine GP, LLC (5.80%) and 1 more | 1,952,550 | 5.80% | 13G (passive) | Jun 17, 2026 |
| Columbia Management Investment Advisers, LLC Joint filing with Ameriprise Financial, Inc. (8.40%) | 1,930,128 | 8.40% | 13G (passive) | Dec 31, 2025 |
| Funicular Funds, LP Joint filing with Cable Car Capital, LP (7.40%), Ma-Weaver Jacob (7.40%) | 1,839,512 | 7.40% | 13G (passive) | Apr 15, 2026 |
| Ameriprise Financial, Inc. Joint filing with Columbia Management Investment Advisers, LLC (5.40%) | 1,350,896 | 5.40% | 13G (passive) amendment | Mar 31, 2026 |
| Heights Capital Management, Inc. Joint filing with CVI Investments, Inc. (9.90%) | 826,145 | 9.90% | 13G (passive) amendment | Jun 30, 2025 |
| Orca Capital AG | 371,142 | 5.70% | 13G (passive) | May 6, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of KTTA | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Cable Car Capital, LP | 3,000,000 | 8.98% | $1.55M | +1,793,621 | 0.03% |
| Stonepine Capital Management, LLC | 2,201,468 | 6.59% | $1.13M | +1,370,167 | 0.64% |
| Adage Capital Partners Gp, L.L.C. | 2,100,000 | 6.28% | $1.08M | – | 0.00% |
| Jupiter Topco LLC | 2,100,000 | 6.28% | $1.09M | New | 0.00% |
| Opaleye Management Inc. | 2,050,000 | 6.14% | $1.06M | New | 0.10% |
| Ameriprise Financial Inc | 1,864,485 | 5.58% | $960.96K | +513,589 | 0.00% |
| Squadron Capital Management LLC | 1,000,000 | 2.99% | $515.40K | −1,100,000 | 0.16% |
| AdvisorShares Investments LLC | 937,550 | 2.81% | $483.21K | +600,042 | 0.06% |
| Vivo Capital, LLC | 465,471 | 1.39% | $239.90K | −1,634,529 | 0.02% |
| Persistent Asset Partners Ltd | 290,555 | 0.87% | $149.75K | – | 0.04% |
| UBS Group AG | 188,111 | 0.56% | $96.88K | +161,962 | 0.00% |
| XTX Topco Ltd | 127,572 | 0.38% | $65.75K | +93,821 | 0.00% |
| Vanguard Capital Management LLC | 126,279 | 0.38% | $65.03K | +72,464 | 0.00% |
| Geode Capital Management, LLC | 83,856 | 0.25% | $43.22K | −20,129 | 0.00% |
| Renaissance Technologies LLC | 65,600 | 0.20% | $33.81K | −27,799 | 0.00% |
| Two Sigma Investments, LP | 64,166 | 0.19% | $33.07K | +43,112 | 0.00% |
| Vanguard Fiduciary Trust Co | 43,860 | 0.13% | $22.59K | – | 0.00% |
| Northern Trust Corp | 31,405 | 0.09% | $16.19K | +12,033 | 0.00% |
| Jump Financial, LLC | 29,363 | 0.09% | $15.13K | New | 0.00% |
| Tower Research Capital LLC (TRC) | 8,838 | 0.03% | $4.56K | +6,984 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 25 | 17M | 50.2% | 5 / 11 | 4 / 0 | 9M | 3M |
| Q1 2026 | 21 | 13M | 38.4% | 3 / 6 | 4 / 6 | 2M | 2M |
| Q4 2025 | 25 | 13M | 38.6% | 11 / 7 | 4 / 5 | 12M | 0M |
| Q3 2025 | 19 | 1M | 1.8% | 10 / 3 | 4 / 2 | 0M | 0M |
| Q2 2025 | 11 | 0M | 0.9% | 4 / 4 | 1 / 1 | 0M | 0M |
| Q1 2025 | 8 | 0M | 0.2% | 3 / 1 | 1 / 2 | 0M | 0M |
| Q4 2024 | 7 | 0M | 0.2% | 1 / 2 | 3 / 0 | 0M | 0M |
| Q3 2024 | 6 | 0M | 0.0% | 1 / 2 | 1 / 2 | 0M | 0M |
| Q2 2024 | 7 | 0M | 0.1% | 2 / 1 | 1 / 1 | 0M | 0M |
| Q1 2024 | 6 | 0M | 0.1% | 6 / 0 | 0 / 0 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
5 funds held KTTA in Q2 2026, 91% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of KTTA | Value | % of fund | As of |
|---|---|---|---|---|---|
| AdvisorShares Psychedelics ETF | 937,550 | 2.81% | $483.21K | 1.09% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 126,279 | 0.38% | $65.08K | 0.00% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 77,601 | 0.23% | $55.51K | 0.00% | May 31, 2026 |
| Fidelity Nasdaq Composite Index Fund | 13,441 | 0.04% | $9.61K | 0.00% | May 31, 2026 |
| Fidelity Series Total Market Index Fund | 7,969 | 0.02% | $5.70K | 0.00% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Tiago Marques | Chief Executive Officer, Director | 73,334 | 0.22% | May 5, 2026 |
| Kartik Krishnan | Chief Medical Officer | – | – | May 5, 2026 |
| Daniel H. Schneiderman | Chief Financial Officer | 26,667 | 0.08% | May 5, 2026 |
| Simon Dumesnil | Director | 35,833 | 0.11% | May 5, 2026 |
| Lawrence Steinman | Director | 199,691 | 0.60% | May 5, 2026 |
| Alfred J. Novak | Director | 3,500 | 0.01% | May 5, 2026 |
| Emer Leahy | Director | 33,333 | 0.10% | May 5, 2026 |
| Capital LP Coastlands | 10% owner | 5,502,549 | 16.47% | Nov 17, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Capital LP Coastlands 10% owner | Nov 17, 2026 | Buy | +875,000 | $0.47 | $411.25K | 5,502,549 |
| Capital LP Coastlands 10% owner | Nov 16, 2026 | Buy | +583,083 | $0.50 | $290.90K | 4,627,549 |
| Capital LP Coastlands 10% owner | Nov 13, 2026 | Buy | +209,431 | $0.50 | $103.79K | 4,044,466 |
| Capital LP Coastlands 10% owner | Jun 17, 2026 | Buy | +100,000 | $0.53 | $53.00K | 3,835,035 |
| Tiago Marques Chief Executive Officer, Director | Nov 28, 2025 | Buy | +33,333 | $0.75 | $25.00K | 73,334 |
| Emer Leahy Director | Nov 28, 2025 | Award | +33,333 | $0.75 | $25.00K | 33,333 |
| Simon Dumesnil Director | Nov 28, 2025 | Buy | +33,333 | $0.75 | $25.00K | 35,833 |
| Daniel H. Schneiderman Chief Financial Officer | Nov 28, 2025 | Award | +26,667 | $0.75 | $20.00K | 26,667 |
| Lawrence Steinman Director | Nov 28, 2025 | Buy | +133,333 | $0.75 | $100.00K | 199,691 |
| Tiago Marques Chief Executive Officer, Director | May 12, 2025 | Sale | −960 | $0.83 | $797 | 40,001 |
| Alfred J. Novak Director | Jun 13, 2024 | Award | +2,750 | $5.62 | $15.46K | 3,500 |
| Alfred J. Novak Director | Jun 12, 2024 | Award | +750 | $5.61 | $4.21K | 750 |
| Lawrence Steinman Director | Jun 2, 2023 | Buy | +30,000 | $0.43 | $12.90K | 1,327,174 |
| Lawrence Steinman Director | Nov 28, 2022 | Award | +5,000 | $0.98 | $4.90K | 1,287,174 |
| Tiago Marques Chief Executive Officer, Director | Nov 25, 2022 | Award | +2,000 | $1.03 | $2.06K | 819,206 |
| Tiago Marques Chief Executive Officer, Director | Nov 23, 2022 | Award | +5,000 | $1.00 | $5.00K | 815,000 |
| Tiago Marques Chief Executive Officer, Director | Nov 23, 2022 | Award | +1,000 | $1.03 | $1.03K | 816,000 |
| Tiago Marques Chief Executive Officer, Director | Nov 23, 2022 | Award | +1,206 | $1.02 | $1.23K | 817,206 |
| Lawrence Steinman Director | Nov 22, 2022 | Award | +5,000 | $0.99 | $4.95K | 1,282,174 |
| Simon Dumesnil Director | Nov 17, 2022 | Award | +40,000 | $1.06 | $42.40K | 50,000 |
| Simon Dumesnil Director | Nov 15, 2022 | Award | +10,000 | $1.07 | $10.70K | 10,000 |
| Lawrence Steinman Director | Oct 26, 2022 | Award | +5,000 | $1.10 | $5.50K | 1,277,174 |
| Tiago Marques Chief Executive Officer, Director | Oct 21, 2022 | Award | +600 | $1.08 | $648 | 805,600 |
| Tiago Marques Chief Executive Officer, Director | Oct 21, 2022 | Award | +4,400 | $1.07 | $4.71K | 810,000 |
| David Delaney – | Oct 17, 2022 | Buy | +1,000 | $1.11 | $1.11K | 227,521 |
| Lawrence Steinman Director | Oct 17, 2022 | Award | +9,000 | $1.13 | $10.17K | 1,272,174 |
| Lawrence Steinman Director | Oct 17, 2022 | Award | +1,000 | $1.14 | $1.14K | 1,263,174 |
| Camac Fund, LP – | Sep 29, 2022 | Buy | +6,710 | $1.16 | $7.78K | 1,788,415 |
| Camac Fund, LP – | Sep 28, 2022 | Buy | +57,647 | $1.19 | $68.60K | 1,781,705 |
| Camac Fund, LP – | Sep 6, 2022 | Buy | +21,748 | $1.13 | $24.58K | 1,724,058 |
| Camac Fund, LP – | Sep 2, 2022 | Buy | +11,507 | $1.14 | $13.12K | 1,702,310 |
| Camac Fund, LP – | Sep 1, 2022 | Buy | +55,646 | $1.13 | $62.88K | 1,690,803 |
| Camac Capital, LLC – | Aug 30, 2022 | Buy | +17,828 | $1.15 | $20.50K | 1,635,157 |
| Camac Capital, LLC – | Aug 29, 2022 | Buy | +5,000 | $1.17 | $5.85K | 1,617,329 |
| Capital LLC Leonite – | Aug 19, 2022 | Buy | +54,644 | $1.30 | $71.04K | 54,644 |
| Camac Fund, LP – | Aug 17, 2022 | Buy | +155,773 | $1.21 | $188.49K | 1,611,329 |
| Lawrence Steinman Director | Jun 29, 2022 | Award | +5,000 | $1.00 | $5.00K | 1,272,174 |
| Lawrence Steinman Director | Jun 28, 2022 | Award | +5,000 | $1.02 | $5.10K | 1,267,174 |
| Lawrence Steinman Director | Jun 27, 2022 | Award | +5,000 | $1.00 | $5.00K | 1,262,174 |
| Lawrence Steinman Director | Jun 23, 2022 | Award | +5,000 | $1.00 | $5.00K | 1,257,174 |
| Tiago Marques Chief Executive Officer, Director | Jun 23, 2022 | Award | +200 | $0.98 | $196 | 803,100 |
| Tiago Marques Chief Executive Officer, Director | Jun 23, 2022 | Award | +1,800 | $0.99 | $1.78K | 805,000 |
| Tiago Marques Chief Executive Officer, Director | Jun 23, 2022 | Award | +100 | $0.99 | $99 | 803,200 |
| Tiago Marques Chief Executive Officer, Director | Jun 23, 2022 | Award | +2,900 | $0.99 | $2.87K | 802,900 |
| Lawrence Steinman Director | Jun 21, 2022 | Award | +652,174 | – | – | 1,252,174 |
| Tiago Marques Chief Executive Officer, Director | Dec 20, 2021 | Award | +200,000 | – | – | 800,000 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Pasithea Therapeutics's stock actually held short. Settlement fails (shares not delivered on time) peaked at 1,638 shares on Sep 30, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Tiago Marques Officer, Director | May 14, 2025 | 960 | $798 | May 12, 2025 | Open market purchase |
See a number that looks wrong?